FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology, and can be used for the complex treatment of colorectal cancer metastases. The method includes the sequential implementation of radical surgical intervention: atypical liver resection and catheterization of the superior vena cava system, the introduction of a chemotherapy drug through the superior vena cava system. In this case, a chemotherapeutic scheme is used, consisting of the drug 5-fluorouracil at a dose of 1200 mg/m2, which has radiosensitizing properties, with the parallel use of intraoperative irradiation with a low-power 50 kV X-ray unit with an irradiation dose of 30 Gy.
EFFECT: use of the invention makes it possible to enhance the chemotherapeutic effect on peri-tumor tissues due to the combined use of surgery and intraoperative chemoradiotherapy.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMPREHENSIVE TREATMENT OF A LOCALLY ADVANCED PANCREATIC DUCTAL ADENOCARCINOMA | 2020 |
|
RU2759045C1 |
METHOD FOR CALCULATING THE AVERAGE LIFE EXPECTANCY IN PATIENTS WITH UNRESECTABLE DISTAL CHOLANGIOCARCINOMA | 2020 |
|
RU2754061C1 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN PRESENCE OF MUTATIONS IN KRAS AND BRAF GENES | 2021 |
|
RU2760174C1 |
METHOD FOR TREATING METASTASES OF COLORECTAL CANCER IN THE LIVER | 2017 |
|
RU2663800C2 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE HEPATIC METASTASES AND IN THE ABSENCE OF MUTATIONS IN THE KRAS AND BRAF GENES | 2021 |
|
RU2764955C1 |
METHOD FOR PREDICTING RELAPSE FREE SURVIVAL IN PATIENTS WITH COLORECTAL CANCER LIVER METASTASES AFTER LIVER RESECTION USING MOLECULAR FACTORS | 2011 |
|
RU2442983C1 |
METHOD FOR COMBINED TREATMENT OF METASTATIC COLORECTAL CANCER IN PATIENTS WITH RESECTABLE LIVER METASTASES IN ABSENCE OF MUTATIONS IN KRAS GENES | 2023 |
|
RU2819653C1 |
METHOD OF PREDICTING RELAPSE-FREE SURVIVAL BY CLINICAL AND PATHOLOGIVCAL FACTORS IN PATIENTS WITH METASTASES OF COLORECTAL CANCER IN LIVER AND AFTER ITS RESECTION | 2011 |
|
RU2452373C1 |
METHOD FOR SELECTING STENT FOR BILIARY DECOMPRESSION IN PATIENTS WITH UNRESECTABLE PORTAL CHOLANGIOCARCINOMA | 2020 |
|
RU2767687C1 |
METHOD OF TREATING RECTAL CANCER WITH SYNCHRONOUS REMOTE METASTASES | 2011 |
|
RU2453345C1 |
Authors
Dates
2021-11-09—Published
2020-12-22—Filed